Copyright
©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 107386
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.107386
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.107386
Figure 1 Gut dysbiosis and its role in atrial fibrillation.
F/B: Firmicutes/Bacteroidetes.
Figure 2 Pathological link between gut dysbiosis and atrial fibrillation.
AF: Atrial Fibrillation; FGF: Fibroblast growth factor; GPCR: G-protein coupled receptor; GPR: G-protein-coupled receptor; IL: Interleukin; LPS: Lipopolysaccharides; NF-κB: Nuclear factor kappa B; NLRP3: Nod-like receptor protein 3; PAGln Phenylacetylglutamine; SCFA: Short-chain fatty acids; TNF: Tumor necrosis factor; TLR: Toll-like receptor; TMAO: Trimethylamine N-oxide.
Figure 3 Gut modulation-based individualized care in atrial fibrillation.
AF: Atrial fibrillation; GPC: G-protein coupled; HF: Heart failure; MI: Myocardial infarction; SCFA: Short-chain fatty acids.
- Citation: Brar AS, Vemula SL, Yanamaladoddi V, Sodhi S, Hatwal J, Sohal A, Batta A. Impact of gut microbiome on atrial fibrillation: Mechanistic insights and future directions in individualized medicine. World J Cardiol 2025; 17(6): 107386
- URL: https://www.wjgnet.com/1949-8462/full/v17/i6/107386.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i6.107386